PeterMD vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats PeterMD overall, scoring 8.2/10 vs 7.3/10. PeterMD is more affordable at $165/mo vs $299/mo. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 . Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of PeterMD and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

PeterMD

#33 of 48

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	PeterMD	Willow
Our Score	7.3/10	8.2/10
Starting Price	$165/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Budget-conscious users looking for the lowest monthly GLP-1 cost	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#33	#8

Pros & Cons Compared

PeterMD

Pros

+Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
+Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
+Video consultations with physicians included — real face-to-face medical oversight

Cons

−Only available in 42 states — excluded from 8 states, limiting nationwide access
−Not BBB accredited, with some documented complaints about delayed medication fulfillment
−Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out PeterMD with a score of 8.2/10 vs 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to Willow's $299/mo. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither PeterMD nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review